Michigan Bureau of Laboratories Supports Public Health
Development Efforts in Uganda
Over the month of June, Dr. Marty Soehnlen, the Microbiology
Section Manager and Director of Infectious Diseases for the Bureau of
Laboratories, provided support to the Uganda Ministry of Health. She was asked
to support the Association of Public Health Laboratories (APHL) Global Health
Program with the goal of setting up the new Ugandan Central Public Health
Laboratory (CPHL). Dr. Soehnlen was responsible for providing assistance to the
new governmental public health laboratory with plan development for
microbiology operations to gain molecular testing capabilities, expansion of
clinical testing services, standard operating procedures development that would
allow for international accreditation, and to provide training for the new
procedures. A three year plan for service expansion to include clinical,
environmental, and molecular assays will allow the microbiologists of CPHL to
offer life-saving services to the people of Uganda.
Michigan Bureau of Laboratories Supports Public Health
Development Efforts in Uganda>>
Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola
Countries must be prepared to respond to public health threats associated with emergencies, such as natural disasters, sociopolitical conflicts, or uncontrolled disease outbreaks. Rapid vaccination of populations vulnerable to epidemic-prone vaccine-preventable diseases is a major component of emergency response. Emergency vaccination planning presents challenges, including how to predict resource needs, expand vaccine availability during global shortages, and address regulatory barriers to deliver new products. The Centers for Disease Control and Prevention supports countries to plan, implement, and evaluate emergency vaccination response. The researchers describe work of the Centers for Disease Control and Prevention in collaboration with global partners to support emergency vaccination against cholera, typhoid, yellow fever, and Ebola, diseases for which a new vaccine or vaccine formulation has played a major role in response. Lessons learned will help countries prepare for future emergencies. Integration of vaccination with emergency response augments global health security through reducing disease burden, saving lives, and preventing spread across international borders.
Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola>>
Guidance on the Transfer of Select Agents and Toxins
This document is intended to provide guidance and assist entities in meeting federal regulatory requirements when transferring or importing a select agent or toxin.
Within the United States, only entities that are registered with the Federal Select Agent Program (FSAP) are allowed to receive material that has been identified as a select agent or toxin. This includes the importation of select agents and toxins from outside the U.S.
Guidance on the Transfer of Select Agents and Toxins>>
|
